{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:15:34Z","timestamp":1788311734247,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.7759\/cureus.115615","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:53:51Z","timestamp":1788310431000},"source":"Crossref","is-referenced-by-count":0,"title":["Radiation-Induced Pneumonitis Following Stereotactic Body Radiation Therapy for Left Upper Lobe Squamous Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Azouba","family":"Gulraiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayush","family":".","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keval","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maulinkumar N","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrithulla Dillibabu","family":"Sujatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanshi","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushalendra","family":"Mani Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinyereugo L","family":"Nwokocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman R","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al.. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010, 303:1070-6. 10.1001\/jama.2010.261","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.05.034","article-title":"Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame","volume":"63","author":"Nagata Y","year":"2005","unstructured":"Nagata Y, Takayama K, Matsuo Y, et al.. Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005, 63:1427-31. 10.1016\/j.ijrobp.2005.05.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v6.i9.708","article-title":"Radiation pneumonitis after stereotactic radiation therapy for lung cancer","volume":"6","author":"Yamashita H","year":"2014","unstructured":"Yamashita H, Takahashi W, Haga A, Nakagawa K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J Radiol. 2014, 6:708-15. 10.4329\/wjr.v6.i9.708","journal-title":"World J Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract11030056","article-title":"Radiation-induced lung injury-current perspectives and management","volume":"11","author":"Rahi MS","year":"2021","unstructured":"Rahi MS, Parekh J, Pednekar P, et al.. Radiation-induced lung injury-current perspectives and management. Clin Pract. 2021, 11:410-29. 10.3390\/clinpract11030056","journal-title":"Clin Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.01.017","article-title":"Incidence and risk factors of symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy and consolidation durvalumab","volume":"22","author":"Shintani T","year":"2021","unstructured":"Shintani T, Kishi N, Matsuo Y, et al.. Incidence and risk factors of symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy and consolidation durvalumab. Clin Lung Cancer. 2021, 22:401-10. 10.1016\/j.cllc.2021.01.017","journal-title":"Clin Lung Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2019.02.008","article-title":"ACR Appropriateness Criteria(\u00ae) Noninvasive Clinical Staging of Primary Lung Cancer","volume":"16","author":"de Groot PM","year":"2019","unstructured":"de Groot PM, Chung JH, Ackman JB, et al.. ACR Appropriateness Criteria(\u00ae) Noninvasive Clinical Staging of Primary Lung Cancer. J Am Coll Radiol. 2019, 16:S184-95. 10.1016\/j.jacr.2019.02.008","journal-title":"J Am Coll Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania AN","year":"2019","unstructured":"Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019, 156:150-62. 10.1016\/j.chest.2019.03.033","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger RB","year":"2012","unstructured":"Barriger RB, Forquer JA, Brabham JG, et al.. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012, 82:457-62. 10.1016\/j.ijrobp.2010.08.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318060f16d","article-title":"Multidisciplinary management of lung cancer","volume":"2","author":"Debevec L","year":"2007","unstructured":"Debevec L, Debeljak A. Multidisciplinary management of lung cancer. J Thorac Oncol. 2007, 2:577. 10.1097\/JTO.0b013e318060f16d","journal-title":"J Thorac Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw P","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, et al.. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016, 11:39-51. 10.1016\/j.jtho.2015.09.009","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","volume":"16","author":"Bradley JD","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R, et al.. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015, 16:187-99. 10.1016\/S1470-2045(14)71207-0","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12574","article-title":"Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: a systematic review","volume":"9","author":"Wang S","year":"2018","unstructured":"Wang S, Wang X, Zhou Q, et al.. Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: a systematic review. Thorac Cancer. 2018, 9:337-47. 10.1111\/1759-7714.12574","journal-title":"Thorac Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?","volume":"81","author":"Onishi H","year":"2011","unstructured":"Onishi H, Shirato H, Nagata Y, et al.. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys. 2011, 81:1352-8. 10.1016\/j.ijrobp.2009.07.1751","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/511690-radiation-induced-pneumonitis-following-stereotactic-body-radiation-therapy-for-left-upper-lobe-squamous-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:53:52Z","timestamp":1788310432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/511690-radiation-induced-pneumonitis-following-stereotactic-body-radiation-therapy-for-left-upper-lobe-squamous-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.115615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}